A trial of CI-564 (dapolar), a repository antimalarial for prophylaxis in Amapá, Brazil.
D000083:Acetanilides / Q000627:therapeutic use; D000655:Amodiaquine / Q000627:therapeutic use*; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D001938:Brazil; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D008288:Malaria / Q000517:prevention & control*; D009281:Naphthalenes / Q000627:therapeutic use; D010963:Plasmodium falciparum; D010966:Plasmodium vivax; D013450:Sulfones / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use
D000083:Acetanilides; D000962:Antimalarials; D003692:Delayed-Action Preparations; D009281:Naphthalenes; D013450:Sulfones; D014227:Triazines; D000655:Amodiaquine